Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 18

1.

Combination gel of 1% amitriptyline and 0.5% ketamine to treat refractory erythromelalgia pain: a new treatment option?

Sandroni P, Davis MD.

Arch Dermatol. 2006 Mar;142(3):283-6. No abstract available.

PMID:
16549702
2.

[Selection of drugs suitable for the treatment of intractable chronic pain patients by using drug challenge tests].

Hanaoka K, Arita H, Nagase M, Ide Y, Tagami M, Hayashida M.

Brain Nerve. 2008 May;60(5):519-25. Review. Japanese.

PMID:
18516974
3.

Chronic administration of ketamine for analgesia.

Ben-Ari A, Lewis MC, Davidson E.

J Pain Palliat Care Pharmacother. 2007;21(1):7-14. Review.

PMID:
17430824
4.

The use of tricyclic antidepressants for the treatment of intractable pain.

Satterthwaite JR, Tollison CD, Kriegel ML.

Compr Ther. 1990 Apr;16(4):10-5. Review. No abstract available.

PMID:
2185912
5.

Treatment options for refractory pain: the role of intrathecal therapy.

Wallace MS.

Neurology. 2002 Sep 10;59(5 Suppl 2):S18-24. Review.

PMID:
12221152
6.

Intrathecal analgesia for refractory cancer pain.

Newsome S, Frawley BK, Argoff CE.

Curr Pain Headache Rep. 2008 Aug;12(4):249-56. Review.

PMID:
18625101
7.

Neuraxial pain relief for intractable cancer pain.

Sloan PA.

Curr Pain Headache Rep. 2007 Aug;11(4):283-9. Review.

PMID:
17686392
8.

How to deal with difficult pain problems.

Cherny NI.

Ann Oncol. 2005;16 Suppl 2:ii79-87. Review. No abstract available.

9.

Pharmacotherapy for neuropathic pain.

Jackson KC 2nd.

Pain Pract. 2006 Mar;6(1):27-33. Review.

PMID:
17309706
10.

Drugs to treat the tissue complications of diabetes: peripheral neuropathy.

Emanuele NV, Emanuele MA.

Compr Ther. 1995 Oct;21(10):579-82. Review. No abstract available.

PMID:
8565426
11.

Tricyclic antidepressants and their local anesthetic properties: from bench to bedside and back again.

Gerner P.

Reg Anesth Pain Med. 2004 May-Jun;29(3):286-9. Review. No abstract available.

PMID:
15138915
12.

[A clinical challenge. Pragmatic treatment of migraine and concomitant depression].

J├╝rgens TP, Leinisch E, Koch HJ.

Schmerz. 2008 Feb;22 Suppl 1:11-6. doi: 10.1007/s00482-007-0608-6. Review. German.

PMID:
18224348
13.

Is intranasal ketamine an appropriate treatment for chronic non-cancer breakthrough pain?

Bell RF, Kalso E.

Pain. 2004 Mar;108(1-2):1-2. Review. No abstract available.

PMID:
15109500
14.

Controlling cancer pain with pharmacotherapy.

Pharo GH, Zhou L.

J Am Osteopath Assoc. 2007 Dec;107(12 Suppl 7):ES22-32. Review.

PMID:
18165374
15.

Ketamine for chronic non-cancer pain.

Bell RF.

Pain. 2009 Feb;141(3):210-4. doi: 10.1016/j.pain.2008.12.003. Epub 2009 Jan 6. Review. No abstract available.

PMID:
19128879
16.

Enriched enrolment with randomised withdrawal (EERW): Time for a new look at clinical trial design in chronic pain.

McQuay HJ, Derry S, Moore RA, Poulain P, Legout V.

Pain. 2008 Apr;135(3):217-20. doi: 10.1016/j.pain.2008.01.014. Epub 2008 Feb 6. Review. No abstract available.

PMID:
18258369
17.

Ketamine.

Sinner B, Graf BM.

Handb Exp Pharmacol. 2008;(182):313-33. doi: 10.1007/978-3-540-74806-9_15. Review.

PMID:
18175098
18.

Erythromelalgia: new theories and new therapies.

Cohen JS.

J Am Acad Dermatol. 2000 Nov;43(5 Pt 1):841-7. Review.

PMID:
11050591
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk